News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
151 Results
Section
Business (22)
Deals (5)
Drug Development (25)
FDA (2)
News (47)
Tag
ADA (2)
Approvals (2)
Cancer (1)
Cardiovascular disease (3)
Clinical research (37)
Collaboration (1)
Compensation (7)
Data (11)
Diabetes (20)
Earnings (21)
Events (54)
FDA (3)
GLP-1 (8)
Healthcare (1)
IPO (5)
Metabolic disorders (21)
Obesity (3)
Patient recruitment (3)
People (6)
Phase 1 (14)
Phase 2 (23)
Pipeline (11)
Preclinical (10)
Regulatory (3)
Date
Today (1)
Last 7 days (1)
Last 30 days (3)
Last 365 days (31)
2026 (14)
2025 (32)
2024 (30)
2023 (31)
2022 (31)
2021 (13)
Location
California (62)
Northern California (61)
United States (62)
151 Results for "biomeafusion".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Biomea Fusion to Participate at Upcoming Investor Conferences - May 12, 2026
May 13, 2026
·
1 min read
Press Releases
Biomea Fusion Announces Poster Presentations of Icovamenib at the American Diabetes Association (ADA) 86th Scientific Sessions
May 6, 2026
·
2 min read
Press Releases
Biomea Fusion to Participate at Upcoming Investor Conferences - February 19, 2026
February 19, 2026
·
1 min read
Press Releases
Biomea Fusion Announces Completion of Enrollment in COVALENT-211 Phase II Trial of Icovamenib in Insulin-Deficient Type 2 Diabetes
August 24, 2026
·
10 min read
Press Releases
Biomea Fusion to Present at the 44th Annual J.P. Morgan Healthcare Conference
December 17, 2025
·
1 min read
Press Releases
Biomea Fusion Announces First Patient Dosed in OPAL Study Evaluating Icovamenib in Combination with Semaglutide in Obesity
August 13, 2026
·
11 min read
Press Releases
Biomea Fusion Reports Second Quarter 2026 Financial Results and Corporate Highlights
August 5, 2026
·
11 min read
Press Releases
Biomea Fusion to Participate in Citi’s SMID Biotech C-Suite Fireside Chat Series
October 21, 2025
·
1 min read
Press Releases
Biomea Fusion Announces Research Collaboration with University of Leicester to Evaluate Icovamenib in Combination with Semaglutide in Obesity
June 3, 2026
·
9 min read
Press Releases
Biomea Fusion to Participate at Upcoming December 2025 Investor Conferences
November 24, 2025
·
1 min read
1 of 16
Next
